Itraconazole

CAS 2049588-24-9 13 current records 6 historicalSmall Molecule

Who holds supplier records for Itraconazole? 13 organisations hold a current record for Itraconazole: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (9), Belgium (1), Spain (1) and United States (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Itraconazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/itraconazole

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    9 of the 12 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Itraconazole expires 21 Jun 2033. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Itraconazole. Country is the organisation's recorded country, not necessarily the manufacturing site.

India9Belgium1Spain1United States1Country not recorded for 1
Need Itraconazole sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Itraconazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
NOSCH LABS PRIVATE LIMITED HyderabadIN
CEP 2018-173 - Rev 02
Itraconazole, Unit-IV
Jun 2026—
SMS PHARMACEUTICALS LIMITED HyderabadIN
CEP 2012-403 - Rev 02
Itraconazole, Bachupally site
Jun 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2005-269 - Rev 08
Itraconazole
May 2026—
VASUDHA PHARMA CHEM LIMITED HyderabadIN
CEP 2020-265 - Rev 03
Itraconazole
Feb 2025—
AKTINOS PHARMA PRIVATE LIMITED HyderabadIN
CEP 2022-317 - Rev 00
Itraconazole
Nov 2024—
COHANCE LIFESCIENCES LIMITED HyderabadIN
R1-CEP 2014-165 - Rev 02
Itraconazole
Apr 2023—
STYRAX PHARMA PRIVATE LIMITED VisakhapatnamIN
R0-CEP 2019-105 - Rev 00
Itraconazole
Oct 2022—
W. R. GRACE & CO.-CONN. ColumbiaUS
R1-CEP 1999-196 - Rev 04
Itraconazole
Jul 2021—
QUIMICA SINTETICA S.A. Alcala De HenaresES
R1-CEP 2016-006 - Rev 00
Itraconazole, Process II
Apr 2021—
JANSSEN PHARMACEUTICA NV BeerseBE
R1-CEP 1999-092 - Rev 07
Itraconazole, Method 1
Feb 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Itraconazole are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • ALP PHARM BEIJING CO LTD
    Inactive DMF 23641 · filed Mar 2010
  • SOCIETA ITALIANA MEDICINALI SCANDICCI
    Inactive DMF 17921 · filed Dec 2004
  • APOTECNIA SA
    Inactive DMF 17292 · filed Mar 2004
  • PIRAMAL HEALTHCARE LTD
    Inactive DMF 16905 · filed Oct 2003
  • India · Inactive DMF 15728 · filed Nov 2001
  • QUIMICA FINA FARMEX SA DE CV
    Inactive DMF 14507 · filed Nov 1999

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (11 listed products contain Itraconazole). The latest listed patent expires 21 Jun 2033. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Itraconazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL64391).

Chemical identity

IUPAC name
2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
Canonical SMILES
CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
InChIKey
VHVPQPYKVGDNFY-UHFFFAOYSA-N
Synonyms
Candistat, Canditral, Cladosal 100, Fungitraxx, Itrac, Itraconazol, Itraconazole, Itraconazole component of suba-, Itralek, Itrizole, NSC-759239, Orungal

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Azole Antifungal
Mechanism of action
Breast Cancer Resistance Protein Inhibitors; Cytochrome P450 3A4 Inhibitors; P-Glycoprotein Inhibitors
Chemical structure
Azoles

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Itraconazole?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Itraconazole: LEE PHARMA LTD (India), COHANCE LIFESCIENCES LTD (India), Janssen Pharmaceutica NV (Belgium), MATRIX PHARMACORP PRIVATE LTD (India), QUIMICA SINTETICA SA (Spain), SMS Pharmaceuticals limited (India), VASUDHA PHARMA CHEM LTD (India) and ALIVUS LIFE SCIENCES LTD (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Itraconazole Drug Master Files are active?

LEE PHARMA LTD (DMF 41456, 41642), COHANCE LIFESCIENCES LTD (DMF 25986), Janssen Pharmaceutica NV (DMF 10725), MATRIX PHARMACORP PRIVATE LTD (DMF 17739), QUIMICA SINTETICA SA (DMF 13012), SMS Pharmaceuticals limited (DMF 25514), VASUDHA PHARMA CHEM LTD (DMF 35261) and ALIVUS LIFE SCIENCES LTD (DMF 17946) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Itraconazole records mean?

6 organisations have only inactive Type II DMFs for Itraconazole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Itraconazole have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Itraconazole on the EDQM register, including NOSCH LABS PRIVATE LIMITED Hyderabad (IN), SMS PHARMACEUTICALS LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), VASUDHA PHARMA CHEM LIMITED Hyderabad (IN), AKTINOS PHARMA PRIVATE LIMITED Hyderabad (IN) and COHANCE LIFESCIENCES LIMITED Hyderabad (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Itraconazole?

Yes. The latest patent listed for an approved US product containing Itraconazole expires 21 Jun 2033, across 11 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Itraconazole supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Itraconazole?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.